European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

By H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, W. Hacke, J. Oldgren, P. Sinnaeve, A. Camm, Paulus Kirchhof. Europace, 2013

837 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/29284ac33f896957d0fb9ee76b8311a514793b2f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Alejandro Rabinstein
2. R. Redberg
3. Nancy R. Cook
4. P. Ridker

Citations in the corpus

• Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage (2016, background): “The European Heart Rhythm Association and others have suggested a dose of 50 units/kg of aPCC for dabigatran-associated bleeding [185, 186].”
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “and 12 days after an ischaemic stroke, depending on stroke severity (Figure 9).(478) We suggest repeat brain imaging to determine the optimal initiation of anticoagulation in patients with a large stroke at”